Chemomab Therapeutics Ltd. Quarterly Return On Assets in % from Q3 2020 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Chemomab Therapeutics Ltd. quarterly/annual Return On Assets history and growth rate from Q3 2020 to Q2 2023.
  • Chemomab Therapeutics Ltd. Return On Assets for the quarter ending June 30, 2023 was -84.2 %, a 172% decline year-over-year.
  • Chemomab Therapeutics Ltd. annual Return On Assets for 2022 was -52.5 %, a 176% decline from 2021.
  • Chemomab Therapeutics Ltd. annual Return On Assets for 2021 was -19 %, a 63.7% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -84.2 -53.2 -172% Apr 1, 2023 Jun 30, 2023
Q1 2023 -67.8 -43.7 -181% Jan 1, 2023 Mar 31, 2023
Q4 2022 -52.5 -33.5 -176% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42.1 -24.3 -136% Jul 1, 2022 Sep 30, 2022
Q2 2022 -31 -10.7 -52.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -24.1 +2.28 +8.64% Jan 1, 2022 Mar 31, 2022
Q4 2021 -19 +33.5 +63.7% Oct 1, 2021 Dec 31, 2021
Q3 2021 -17.8 +55.1 +75.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -20.3 Apr 1, 2021 Jun 30, 2021
Q1 2021 -26.4 Jan 1, 2021 Mar 31, 2021
Q4 2020 -52.5 Oct 1, 2020 Dec 31, 2020
Q3 2020 -73 Jul 1, 2020 Sep 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.